Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Korean Journal of Obstetrics and Gynecology ; : 1693-1701, 2003.
Artigo em Coreano | WPRIM | ID: wpr-33842

RESUMO

OBJECTIVE: To evaluate pathological complete remission rate (pCR), survival rate, recurrence rate, 91 patients who had clinical complete remission with epithelial ovarian cancer were studied. METHODS: From 1983 to 2002, 91 consecutive patients with epithelial ovarian cancer underwent surgical cytoreduction followed by platinum-based chemotherapy at the Department of Obstetrics and Gynecology, Hanyang University Hospital. At the conclusion of chemotherapy, all patients who were clinically disease free and whose CA 125 was 2 cm with advanced stage at primary surgery and negative second-look findings should be the focus of future protocols for consolidation chemotherapy.


Assuntos
Humanos , Quimioterapia de Consolidação , Tratamento Farmacológico , Ginecologia , Laparotomia , Modelos Logísticos , Neoplasia Residual , Obstetrícia , Neoplasias Ovarianas , Patologia , Recidiva , Terapia de Salvação , Taxa de Sobrevida
2.
Korean Journal of Gynecologic Oncology and Colposcopy ; : 93-99, 1996.
Artigo em Coreano | WPRIM | ID: wpr-84815

RESUMO

A study was to evaluate the efficacy and clinical utility of second look operation in the managements of malignant ovarian tumor at the Department of Obstetrics and Gynecology, Kosin medical colleage from January 1986 to September 1993. Of 220 patients diagnosed as ovarian cancer, 48 patients who had underwent primariy laparotomy were performed second look operation. Thirty-seven patients were found to have no evidence of disease. The result revealed that negative second look operation rate was noted 96.3% at stage I, 66.6% at stage II, 50.0% at stage III, and 42.9% at stage IV and total negative second look operation rate was 77.1%. The 2 year survival rate for stage I, II, III, IV were 85.2%, 66.6%, 50.0% and 42.9% respectively. The survival rate of negative second look operation was 86.5%, that of positive second look operation was 18.1%. In conclusion, second look operation in early stage ovarian cancer need to be justified.


Assuntos
Humanos , Seguimentos , Ginecologia , Laparotomia , Obstetrícia , Neoplasias Ovarianas , Taxa de Sobrevida
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA